首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Comparison of Outcomes with Two Calcineurin Inhibitor Based Graft-Versus-Host-Disease Prophylactic Regimens after Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

【24h】

Comparison of Outcomes with Two Calcineurin Inhibitor Based Graft-Versus-Host-Disease Prophylactic Regimens after Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

机译：降低强度调节同种异体造血细胞移植治疗血液系统恶性肿瘤后，两种基于钙调神经磷酸酶抑制剂的移植物抗宿主病预防方案的疗效比较

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2016年第1期|共2页
作者
Khanal Rashmi; Sedov Valeriy; Gupta Ridhi; Burbridge Mark Thomas; Butcher Colleen; Capdevila Kylie; Edwards Kathy Hogan; Martin Kristy; Littleton Amanda; Kramer Cindy; Schneider Molly; Varela Juan Carlos; Williams Elizabeth J.; Stuart Robert; Chhabra Saurabh; Gentles Carolyn Ann;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Comparison of Outcomes with Two Calcineurin Inhibitor Based Graft-Versus-Host-Disease Prophylactic Regimens after Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies [J] . Khanal Rashmi, Sedov Valeriy, Gupta Ridhi, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：降低强度调节同种异体造血细胞移植治疗血液系统恶性肿瘤后，两种基于钙调神经磷酸酶抑制剂的移植物抗宿主病预防方案的疗效比较
2. Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [J] . Monzr M. Al Malki, Nitya Nathwani, Dongyun Yang, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第9期

机译：基于Melphalan的减少强度调节与70岁的患者有良好的疾病控制和可接受的毒性有关，血液学恶性肿瘤患者经历了同种异体造血干细胞移植
3. Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: A single-center analysis [J] . LeBourgeoisA., MohrC., GuillaumeT., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2013,第6期

机译：两种护理标准降低强度条件治疗方案和两种不同移植来源的成人血液病同种异体干细胞移植后的结局比较：单中心分析
4. Fludarabine Phosphete and Melphalan - An Immunosuppressive Reduced Intensity Conditioning (RIC) Regimen for AUogeneic Stem Cell Transplantation in Patients with a Range of Hematological Malignancies [C] . G. Jackson, C. Richardson, G. Morgan, European Haematology Association . 2002

机译：Fludarabine phospete和Melphalan - 一种免疫抑制性降低的强度调理（RIC）治疗患者血液学恶性肿瘤患者的促孕酮干细胞移植方案
5. Combinatorial therapeutic vaccination strategies for hematologic malignancies in the early period following experimental autologous hematopoietic stem cell transplantation. [D] . Newman, Robert G. 2014

机译：实验性自体造血干细胞移植后早期的血液系统恶性肿瘤的组合治疗接种策略。
6. Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen for elderly patients (60 years and older) with hematologic malignancies using unrelated donors: a retrospective study from the French society for stem cell transplantation (SFGM-TC) [O] . Jean El Cheikh, Patrick Sfumato, Mohamad Sobh, 2016

机译：使用无关供体的老年恶性血液病患者（60岁及以上）在降低强度条件后进行同种异体造血干细胞移植：法国社会对干细胞移植的回顾性研究（SFGM-TC）
7. An Identical Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic (ALLO) Hematopoietic Stem Cell Transplantation (HSCT) in 222 Patients with Hematologic Malignancies: A Monocenter Experience [O] . Blaise Didier, Castagna Luca, Venton Geoffroy, 2013

机译：222例血液系统恶性肿瘤患者同种异体（ALLO）造血干细胞移植（HSCT）之前的同等强度调节（RIC）方案：单中心经验

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号